전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Gao L, Li H, Li B, Shao H, Yu X, Miao Z, et al. 2022. Traditional uses, phytochemistry, transformation of ingredients and pharmacology of the dried seeds of Raphanus sativus L. (Raphani Semen), A comprehensive review. J. Ethnopharmacol. 294: 115387.
    Pubmed CrossRef
  2. Zheng W, Li X, Zhang T, Wang J. 2022. Biological mechanisms and clinical efficacy of sulforaphane for mental disorders. Gen. Psychiatr. 35: e100700.
    Pubmed PMC CrossRef
  3. Kow CS, Ramachandram DS, Hasan SS. 2022. Use of sulforaphane in COVID-19: Clinical trials are needed. Mol. Immunol. 145: 78-79.
    Pubmed PMC CrossRef
  4. Dana AH, Alejandro SP. 2022. Role of sulforaphane in endoplasmic reticulum homeostasis through regulation of the antioxidant response. Life Sci. 299: 120554.
    Pubmed CrossRef
  5. Wang L, Jiang H, Liang X, Zhou W, Qiu Y, Xue C, et al. 2021. Preparation of sulforaphene from radish seed extracts with recombinant food-grade Yarrowia lipolytica harboring high myrosinase activity. J. Agric. Food Chem. 69: 5363-5371.
    Pubmed CrossRef
  6. Lim S, Han S-W, Kim J. 2016. Sulforaphene identified from radish (Raphanus sativus L.) seeds possesses antimicrobial properties against multidrug-resistant bacteria and methicillin-resistant Staphylococcus aureus. J. Funct.Foods 24: 131-141.
    CrossRef
  7. Gao L, Du F, Wang J, Zhao Y, Liu J, Cai D, et al. 2021. Examination of the differences between sulforaphane and sulforaphene in colon cancer: A study based on next-generation sequencing. Oncol. Lett. 22: 690.
    Pubmed PMC CrossRef
  8. Zhang G, Jin C, Zhu Y, Fu F, Wang G, Li S. 2020. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway. Life Sci. 263: 118485.
    Pubmed CrossRef
  9. Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX. 2020. Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K/Akt/GSK-3β pathway in experimental models of Alzheimer's disease. Oxid. Med. Cell Longev. 2020: 4754195.
    Pubmed PMC CrossRef
  10. Yang H, Kang MJ, Hur G, Lee TK, Park IS, Seo SG, et al. 2020. Sulforaphene suppresses adipocyte differentiation via induction of post-translational degradation of CCAAT/enhancer binding protein Beta (C/EBPβ). Nutrients 12: 758.
    Pubmed PMC CrossRef
  11. Valente Duarte De Sousa IC. 2019. New and emerging drugs for the treatment of acne vulgaris in adolescents. Expert Opin. Pharmacother. 20: 1009-1024.
    Pubmed CrossRef
  12. Williams HC, Dellavalle RP, Garner S. 2012. Acne vulgaris. Lancet 379: 361-372.
    Pubmed CrossRef
  13. Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. 2022. Acne treatment review and future perspectives. Dermatol. Ther. 35: e15719.
    CrossRef
  14. Andersen RK, Bouazzi D, Erikstrup C, Nielsen KR, Burgdorf KS, Bruun MT, et al. 2022. The social and psychological impact of acne treatment: A cross-sectional study of blood donors. J. Cutan. Med. Surg. 26: 485-493.
    Pubmed CrossRef
  15. Marron SE, Chernyshov PV, Tomas-Aragones L. 2019. Quality-of-life research in acne vulgaris: current status and future directions. Am. J. Clin. Dermatol. 20: 527-538.
    Pubmed CrossRef
  16. Tanghetti EA. 2013. The role of inflammation in the pathology of acne. J. Clin. Aesthet. Dermatol. 6: 27-35.
  17. Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, et al. 2014. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J. Eur. Acad. Dermatol. Venereol. 28: 271-278.
    Pubmed CrossRef
  18. Temiz SA, Daye M. 2022. Dapsone for the treatment of acne vulgaris: do the risks outweigh the benefits? Cutan. Ocul. Toxicol. 41: 60-66.
    Pubmed CrossRef
  19. Suh HD. 2010. Pharmacologic treatment acne. J. Korean Med. Assoc. 53: 623-629.
    CrossRef
  20. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. 2005. What is the pathogenesis of acne? Exp. Dermatol. 14: 143-152.
    Pubmed CrossRef
  21. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. 2016. Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 74: 945-973.
    Pubmed CrossRef
  22. Boen M, Jacob C. 2019. A Review and update of treatment options using the acne scar classification system. Dermatol. Surg. 45: 411-422.
    Pubmed CrossRef
  23. Oh JH, Kim SH, Kwon OK, Kim JH, Oh SR, Han SB, et al. 2022. Purpurin suppresses atopic dermatitis via TNF-α/IFN-γ-induced inflammation in HaCaT cells. Int. J. Immunopathol. Pharmacol. 36: 3946320221111135.
    Pubmed PMC CrossRef
  24. Jayasinghe AMK, Kirindage K, Fernando IPS, Han EJ, Oh GW, Jung WK, et al. 2022. Fucoidan Isolated from Sargassum confusum suppresses inflammatory responses and oxidative stress in TNF-α/IFN-γ-stimulated HaCaT keratinocytes by activating Nrf2/HO-1 signaling pathway. Mar. Drugs 20: 117.
    Pubmed PMC CrossRef
  25. Heo Y, Yeo KU, Cha WS, Yeon DE, Choi SH, Lee JY, et al. 2013. Development of skin sensitization alternative test through co-culture of THP-1 dendritic cell line and HaCaT keratinocyte cell line. J. Alternat. Anim. Exp. 7: 29-34.
  26. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. 2002. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169: 1535-1541.
    Pubmed PMC CrossRef
  27. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, et al. 2002. Propionibacterium acnes-induced IL-8 production may be mediated by NF-κB activation in human monocytes. J. Dermatol. Sci. 29: 97-103.
    Pubmed CrossRef
  28. Zhang B, Choi YM, Lee J, An IS, Li L, He C, et al. 2019. Toll-like receptor 2 plays a critical role in pathogenesis of acne vulgaris. Biomed. Dermatol. 3: 4.
    CrossRef
  29. Hernandez-Quintero M, Kuri-Harcuch W, Gonzalez Robles A, Castro-Munozledo F. 2006. Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture. Cell Tissue Res. 325: 77-90.
    Pubmed CrossRef
  30. Dixit N, Simon SI. 2012. Chemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrest. Front. Immunol. 3: 188.
    Pubmed PMC CrossRef
  31. Fang F, Xie Z, Quan J, Wei X, Wang L, Yang L. 2020. Baicalin suppresses Propionibacterium acnes-induced skin inflammation by downregulating the NF-κB/MAPK signaling pathway and inhibiting activation of NLRP3 inflammasome. Braz. J. Med. Biol. Res. 53: e9949.
    Pubmed PMC CrossRef
  32. Kim J. 2005. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211: 193-198.
    Pubmed CrossRef
  33. Kistowska M, Gehrke S, Jankovic D, Kerl K, Fettelschoss A, Feldmeyer L, et al. 2014. IL-1beta drives inflammatory responses to propionibacterium acnes in vitro and in vivo. J. Invest. Dermatol. 134: 677-685.
    Pubmed CrossRef

Related articles in JMB

More Related Articles

Article

Research article

J. Microbiol. Biotechnol. 2022; 32(11): 1390-1395

Published online November 28, 2022 https://doi.org/10.4014/jmb.2209.09051

Copyright © The Korean Society for Microbiology and Biotechnology.

Sulforaphene Attenuates Cutibacterium acnes-Induced Inflammation

Hwan Ju Hwang1, Jong-Eun Kim2*, and Ki Won Lee1*

1WCU Biomodulation Major and Research Institute of Agriculture and Life Sciences, Department of Agricultural Biotechnology, Seoul National University, Seoul 08826, Republic of Korea
2Department of Food Science and Technology, Korea National University of Transportation, Jeungpyeong 27909, Republic of Korea

Correspondence to:Jong-Eun Kim,       jekim14@ut.ac.kr
Ki Won Lee,          kiwon@snu.ac.kr

Received: September 30, 2022; Revised: October 17, 2022; Accepted: October 18, 2022

Abstract

Acne is a chronic inflammatory disease of the sebaceous gland attached to the hair follicles. Cutibacterium acnes is a major cause of inflammation caused by acne. It is well known that C. acnes secretes a lipolytic enzyme to break down lipids in sebum, and free fatty acids produced at this time accelerate the inflammatory reaction. There are several drugs used to treat acne; however, each one has various side effects. According to previous studies, sulforaphene (SFEN) has several functions associated with lipid metabolism, brain function, and antibacterial and anti-inflammatory activities. In this study, we examined the effects of SFEN on bacterial growth and inflammatory cytokine production induced by C. acnes. The results revealed that SFEN reduced the growth of C. acnes and inhibited proinflammatory cytokines in C. acnes-treated HaCaT keratinocytes through inhibiting NF-κB-related pathways. In addition, SFEN regulated the expression level of IL-1α, a representative pro-inflammatory cytokine expressed in co-cultured HaCaT keratinocytes and THP-1 monocytes induced by C. acnes. In conclusion, SFEN showed antibacterial activity against C. acnes and controlled the inflammatory response on keratinocytes and monocytes. This finding means that SFEN has potential as both a cosmetic material for acne prevention and a pharmaceutical material for acne treatment.

Keywords: Acne, Cutibacterium acnes, inflammation

Introduction

Radish seeds have long been used in East Asian traditional medicine for antibacterial purposes and to treat intestinal and skin inflammation [1]. Sulforaphene (SFEN, Fig. 1A), an active compound in radish seeds and a highly studied phytochemical, is a material that gives sulforaphane its carbon double bonds [2-4]. Additionally, SFEN is involved in lipid metabolism [5], has antibacterial effects on different types of bacteria [6], and also alleviates inflammatory diseases, including cancer [5, 7-10].

Figure 1. Effects of sulforaphene (SFEN) on HaCaT cell viability. (A) Chemical structure of SFEN. (B) MTT assay results showed that SFEN did not exhibit cytotoxicity until 20 μM concentration. All graphs represent the means ± SEM (n = 3). Asterisks indicate a significant inhibition by SFEN compared with non-treated group (**p < 0.01) using Student’s t-test.

Acne is a chronic inflammatory disease of the sebaceous glands, usually starting in puberty and disappearing in a person’s mid-20s [11]. Clinically, it appears in the form of comedones, pustules, cysts, and nodules [12]. It mainly appears on the face, neck, and chest where there is a lot of sebum secretion. As a result, it sometimes leaves unpleasant scarring on the skin [13]. The condition is not only a cosmetic concern, it also causes various psychological problems [14]. Acne occurs for a variety of reasons. In women, acne sometimes worsens periodically [13], usually about 1-2 weeks before menstruation, and it is thought to be caused by a progesterone hormone. Patients with endocrine disorders are particularly prone to acne [15], while various additives in cosmetics can also be a cause [16]. Physical and mental stress, such as lack of sleep and overwork, can exacerbate acne by increasing the secretion of androgens [17]. Acne worsens in strong sunlight or in hot, humid environments. If an affected individual constantly touches, rubs, or presses on acne, secondary infection and spread of the condition can also occur [13].

During puberty, an excess of male hormone can activate secretion of the sebaceous glands, and the epithelium of the hair follicles is complete and immature keratinization occurs, which is an abnormal keratinization called heterokeratosis [18]. Among the bacteria resident in hair follicles is Cutibacterium acnes, which secretes a lipolytic enzyme that decomposes triglycerides in sebum to form free fatty acids and stimulate hair follicles. In addition, the immunological response to C. acnes contributes to the inflammatory response of acne [17]. Acne that has been severely stagnant is unsightly, but it is highly likely to remain as a scar, so it is treated with injection therapy to reduce the occurrence of scars [19]. When acne is spread widely, chemical peeling is used to exfoliate dead skin cells and temporarily open clogged pores, reduce inflammation, and increase skin absorption of other medications, thereby enhancing the efficacy of the drug. While physical treatment is expensive and painful [12], current drug therapy against acne aims to suppress C. acnes proliferation, control sebum secretion, and prevent hyperkeratinization and inflammatory reaction. Topical treatments include antibiotics, retinoids, benzoyl peroxide, and azelaic acid [20]. These are often accompanied by side effects such as dryness, contact allergic reaction, erythema, epidermal deprivation, burning sensation, and skin irritation [12]. Systemic therapy includes antibiotics, isotretinoin, and hormone preparations, which can also cause diarrhea, nausea, dry skin, depression, vomiting, and headaches [21]. As such, existing acne treatments are limited due their various side effects [22]. Therefore, in recent years, attempts have been made to develop acne treatments that lessen these side effects. In this study, we reveal the efficacy of treating acne by SFEN using HaCaT cells, which are keratinocytes of the skin. The mechanism of action was also elucidated.

Materials and Methods

Chemicals and Reagents

SFEN was obtained from LKT Laboratories, Inc. (USA). Among the antibodies, p-IκBα (Ser32) and p-IKKα/β (Ser176/180) were obtained from Cell Signaling Biotechnology (USA). Other antibodies were obtained from Santa Cruz Biotechnology, Inc. (USA). DMEM, RPMI-1640 and fetal bovine serum (FBS) were obtained from Welgene, Inc. (Korea). Brain heart infusion broth, a GasPak system, and brain heart infusion agar (BD Biosciences, Inc., USA) were used to culture C. acnes. A protein quantification kit was purchased from Bio-Rad. Other chemicals were purchased from MilliporeSigma, Inc. (USA).

Cell Culture

HaCaT cells were cultured in DMEM with 10% FBS at 5% CO2 and 37°C. RPMI-1640 medium is used for culture of Human THP-1 promonocytic cells. Each cell was seeded and, when it reached 80% confluence, was replaced with serum-free media for starvation. After 1 h of treatment with SFEN, heat-killed C. acnes (multiplicity of infection [MOI] = 100) was added to the medium. In co-culture experiments, 1.0 × 105 cells/well of HaCaT cells were seeded in the upper chamber of a 12-well Transwell (Corning Inc., USA). THP-1 cells were seeded in the lower chamber at 2.0 × 105 cells/well. Then, following treatment with SFEN (5, 10, and 20 mM), heat-killed C. acnes (MOI = 100) was treated 1 h later.

Bacterial Culture

Brain heart infusion broth is used for culturing C. acnes ATCC 6919 under anaerobic conditions. A GasPak system was used to produce anaerobic conditions. The pellets were treated at 65°C for 30 min before being dissolved in DMEM.

Luciferase Reporter Gene Assay and Enzyme-Linked Immunosorbent Assay (ELISA)

pGF-NF-κB-mCMV-EF1-Puro was purchased from System Biosciences, Inc. (USA). A Luciferase Assay Kit was also obtained (Promega Inc., USA), as were human IL-1β, human IL-6, and a Human IL-8/CXCL8 DuoSet ELISA Kit (R&D Systems, Inc., USA). All items were used according to the manufacturer’s instructions.

qPCR

RNAs from HaCaT cells were prepared by using RNAiso Plus (Takara Bio Inc., Japan). The concentration and purity of the RNAs were measured using a NanoDrop ND-2000 spectrophotometer (Thermo Fisher Scientific, USA). A PrimeScriptTM 1st Strand cDNA Synthesis Kit (Takara Bio Inc.) was used for reverse transcription. IQ SYBR (Bio-Rad Laboratories Inc., USA) was used for RT-PCR. cDNA (2 μl) was used in triplicate with GAPDH as an internal control. cDNA was amplified using the following primers: IL-8 forward (5’- TCT TGG CAG CCT TCC TGA TT -3’), IL-8 reverse (5’- TTT CGT GTT GGC GCA GTG T -3’); IL-6 forward (5’- CAA TCT GGA TTC AAT GAG GAG AG -3’); IL-6 reverse (5’- CTC TGG CTT GTT CCT CAC TAC TC -3’); GAPDH forward (5’-TCC TCA CCC TGA AGT ACC CCA T –3’); GAPDH reverse (5’- AGC CAC ACG CAG CTC ATT GTA -3’).

Western Blot Assay

Protein lysates (60 mg) were separated by SDS-PAGE and transferred onto a PVDF membrane (MilliporeSigma, Inc.). The membrane was blocked in skim milk over 2 h and then incubated with an indicated primary antibody over 6 h. After washing 3 times, hybridization was carried out with an HRP-conjugated secondary antibody. A chemiluminescence detection kit from MilliporeSigma, Inc. was used for protein bands.

Statistical Analysis

One-way analysis of variance (ANOVA) and post-hoc Tukey's test were used. p-values < 0.05 were considered statistically significant. IBM SPSS Statistics v.23.0 (IBM, UAS) was used for statistical analysis. The data were expressed as means ± standard error of the mean (SEM).

Results

Effects of SFEN on C. acnes Growth

An MIC test was performed to determine the antibacterial effect of SFEN. The strains used for MIC were C. acnes, E. coli CCARM 9008, CCARM 3102, or S. aureus CCARM 3102 (Table 1). In particular, SFEN inhibited the growth of C. acnes more so than that of other bacteria. Therefore, SFEN exhibits a direct antibacterial effect against C. acnes.

Table 1 . Minimum inhibitory concentration (MIC) test for SFEN..

Microbial strainsMinimum inhibitory concentration (MIC)

SFEN (mM)Norfloxacin (mM)Clindamycin (mM)
C. acnes CCARM 90080.31-0.07
E. coli CCARM 00121.250.38-
S. aureus CCARM 31021.25100.21-
E. coli ATCC 259221.250.19-
S. aureus ATCC 292131.253.13-
S. pneumoniae CCARM 00311.25--


Effects of SFEN on Proinflammatory Cytokines in C. acnes-Treated HaCaT Keratinocytes

To conduct the experiment at a concentration without cytotoxicity, the MTT assay was performed. As in Fig. 1B, SFEN shows decreased viability at concentrations above 40 μM. Therefore, another experiment was conducted with an SFEN concentration of less than 20 μM, which does not affect cell death. The protein levels of IL-6 and IL-8, the major cytokines produced by C. acnes, were measured through ELISA. SFEN effectively inhibited these cytokines (Figs. 2A and 2B). As in Figs. 2C and 2D, the mRNA levels of IL-6 and IL-8 were also effectively inhibited by SFEN.

Figure 2. Effects of SFEN on the production of pro-inflammatory cytokines in HaCaT cells. The secretion levels of (A) IL-6, and (B) IL-8 were detected by ELISA. The expression levels of (C) IL-6 mRNA, and (D) IL-8 mRNA were detected using qPCR described in Materials and Methods. Bars marked with different letters (a–c) are significantly different (p < 0.05) according to Tukey's test. The hashes (#) indicate a significant difference (p < 0.05) compared to untreated control.

Effects of SFEN on NF-κB Signaling Pathway Inhibition in HaCaT Keratinocytes

The transcription factor that plays a crucial role in the expression of IL-6 and IL-8 is NF-κB in HaCaT keratinocytes [23, 24]. We used luciferase reporter gene assays to investigate the activation of NF-κB transcription factors. In HaCaT cells transduced with NF-κB reporter plasmid, treatment with C. acnes increases the activity of luciferase, and treatment with SFEN decreases it (Fig. 3A). In addition, SFEN inhibited the phosphorylation of IKKα/β and IκBα (Fig. 3B), which are upstream regulators of NF-κB.

Figure 3. Inhibitory effects of SFEN on the transcription activity of NF-κB and the upstream regulator proteins of NF-κB. (A)Transcription activity of NF-κB was measured by luciferase reporter gene assay described in Materials and Methods. Bars marked with different letters (a–c) are significantly different (p < 0.05) according to Tukey's test. The hashes (#) indicate a significant difference (p < 0.05) compared to untreated control. (B) Phosphorylated and total forms of IKKα/β (Ser176/180) and IκBα (Ser32) proteins were determined by western blot assay as described in Materials and Methods.

Effects of SFEN on C. acnes-Induced IL-1β in Cocultured HaCaT Keratinocytes and THP-1 Monocytes

An experimental method of coculturing two cells was used to simulate a phenomenon occurring in the human body. In the human body, keratinocytes cause skin inflammation through interaction with Langerhans cells. The THP-1 cell line was originally known as a monocytic leukemia cell, but has characteristics of dendritic cells [25]. To show the protein level of IL-1β in the coculture model (Fig. 4A), the cells were divided into three conditioned groups: HaCaT only, THP-1 only, and HaCaT and THP-1. Heat-killed C. acnes was added to each group. IL-1β was increased significantly when HaCaT and THP-1 cells were cocultured (Fig. 4B). In our coculture model, SFEN inhibited IL-1β induced by heat-killed C. acnes in a concentration-dependent manner (Fig. 4C).

Figure 4. Effects of SFEN on the production of IL-1β cytokine in a coculture model of HaCaT cells and THP-1 cells. (A) The coculture method of HaCaT cells and THP-1 cells using Transwells as described in Materials and Methods. (B and C) The concentration of IL-1β in conditioned media was detected by ELISA. White bar indicates C. acnes-induced group and black bar indicates the control group. Bars marked with different letters (a–c) are significantly different (p < 0.05) according to Tukey's test. The hashes (#) indicate a significant difference (p < 0.05) compared to untreated control.

Discussion

The sebaceous glands are abundant on the face, back, and chest areas where acne is common. These glands are connected to hair follicles and produce an oily substance called sebum. [14]. Under normal conditions, sebum rises along the hair follicle wall and is discharged through the skin, but when the hair follicle is blocked, sebum cannot be discharged and gets trapped around the hair follicle, and bacteria that cause inflammation grow, which leads to acne [11]. Among the bacteria resident in hair follicles, C. acnes, in particular, secretes lipolytic enzymes to form free fatty acids and stimulate hair follicles. It is also known that an immune response to these bacteria contributes to acne inflammation [15]. Therefore, if C. acnes can be prevented from growing on the skin and the inflammation caused by it can be alleviated, the damage to the skin caused by acne can be reduced [14]. In this study, we found that SFEN exerts antibacterial activity against C. acnes and relieves related inflammation.

C. acnes promotes this inflammation through Toll-like receptor (TLR) activation. Among TLRs, TLR2 plays the most important role in inflammation caused by C. acnes. Activation of TLR2 by C. acnes induces the MAPK and NF-κB pathways. Activated NF-κB transcription factors promote the expression of proinflammatory cytokines [26, 27]. Activation of TLR2 by C. acnes induces proinflammatory cytokines such as IL-8 and IL-6 in keratinocytes [28]. These cytokines play roles in regulating inflammatory responses in keratinocytes and monocytes [29, 30]. In this study, SFEN inhibited the transcriptional activity of NF-κB by suppressing IkBα and IKKα/β phosphorylation, which regulates NF-κB activation.

There are many reports that C. acnes contributes to the production of cytokines that are pivotal in inflammatory acne via a TLR2 pathway [31]. C. acnes-induced cytokine production is associated with TLR2 activation. C. acnes induces the production of IL-1β, IL-8, TNF-α and IFN-γ in keratinocytes [28]. It has been shown that peritoneal macrophages from knockout of TLR6 and TLR1 in mice produce IL-6 in response to C. acnes infection, but not TLR2 knockout mice [32]. Therefore, C. acnes activates TLR2 and TLR2 activates NF-κB. Activated NF-κB induces various inflammatory responses. SFEN can block NF-κB activation, thereby preventing inflammation caused by C. acnes.

A coculture model of HaCaT and THP-1 cells was used to evaluate the effects of the material more similar to an in vivo situation. The cytokines produced by C. acnes-induced keratinocytes act on immune cells in the skin. These cytokines induced other proinflammatory cytokines, such as IL-1β [33]. IL-1β secretion was strongly increased when C. acnes was treated in a coculture model than when HaCaT cells and THP-1 cells were treated with C. acnes, respectively. When SFEN was treated in a coculture model, IL-1β secretion induced by C. acnes was inhibited. This suggests that SFEN could inhibit inflammation occurring at acne sites.

In conclusion, we identified effects of SFEN on the growth of C. acnes and C. acnes-induced inflammation. Our findings demonstrate that SFEN has potential both as a cosmetic material for acne prevention, and as a pharmaceutical material for acne treatment.

Acknowledgments

This work was supported by the Regional Innovation Strategy (RIS) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (MOE)(2021RIS-001), a Korea Technology and Information Promotion Agency for SMEs (TIPA) grant funded by the Korea government (Ministry of SMEs and Startups) (No. S3174595), National Research Foundation of Korea(NRF) grant funded by the Korea government (MSIT)(2019R1C1C1004387), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry(IPET) through Technology Commercialization Support Program, funded by Ministry of Agriculture, Food and Rural Affairs(MAFRA)(821027) and the Korea National University of Transportation 2022.

Conflict of Interest

The authors have no financial conflicts of interest to declare.

Fig 1.

Figure 1.Effects of sulforaphene (SFEN) on HaCaT cell viability. (A) Chemical structure of SFEN. (B) MTT assay results showed that SFEN did not exhibit cytotoxicity until 20 μM concentration. All graphs represent the means ± SEM (n = 3). Asterisks indicate a significant inhibition by SFEN compared with non-treated group (**p < 0.01) using Student’s t-test.
Journal of Microbiology and Biotechnology 2022; 32: 1390-1395https://doi.org/10.4014/jmb.2209.09051

Fig 2.

Figure 2.Effects of SFEN on the production of pro-inflammatory cytokines in HaCaT cells. The secretion levels of (A) IL-6, and (B) IL-8 were detected by ELISA. The expression levels of (C) IL-6 mRNA, and (D) IL-8 mRNA were detected using qPCR described in Materials and Methods. Bars marked with different letters (a–c) are significantly different (p < 0.05) according to Tukey's test. The hashes (#) indicate a significant difference (p < 0.05) compared to untreated control.
Journal of Microbiology and Biotechnology 2022; 32: 1390-1395https://doi.org/10.4014/jmb.2209.09051

Fig 3.

Figure 3.Inhibitory effects of SFEN on the transcription activity of NF-κB and the upstream regulator proteins of NF-κB. (A)Transcription activity of NF-κB was measured by luciferase reporter gene assay described in Materials and Methods. Bars marked with different letters (a–c) are significantly different (p < 0.05) according to Tukey's test. The hashes (#) indicate a significant difference (p < 0.05) compared to untreated control. (B) Phosphorylated and total forms of IKKα/β (Ser176/180) and IκBα (Ser32) proteins were determined by western blot assay as described in Materials and Methods.
Journal of Microbiology and Biotechnology 2022; 32: 1390-1395https://doi.org/10.4014/jmb.2209.09051

Fig 4.

Figure 4.Effects of SFEN on the production of IL-1β cytokine in a coculture model of HaCaT cells and THP-1 cells. (A) The coculture method of HaCaT cells and THP-1 cells using Transwells as described in Materials and Methods. (B and C) The concentration of IL-1β in conditioned media was detected by ELISA. White bar indicates C. acnes-induced group and black bar indicates the control group. Bars marked with different letters (a–c) are significantly different (p < 0.05) according to Tukey's test. The hashes (#) indicate a significant difference (p < 0.05) compared to untreated control.
Journal of Microbiology and Biotechnology 2022; 32: 1390-1395https://doi.org/10.4014/jmb.2209.09051

Table 1 . Minimum inhibitory concentration (MIC) test for SFEN..

Microbial strainsMinimum inhibitory concentration (MIC)

SFEN (mM)Norfloxacin (mM)Clindamycin (mM)
C. acnes CCARM 90080.31-0.07
E. coli CCARM 00121.250.38-
S. aureus CCARM 31021.25100.21-
E. coli ATCC 259221.250.19-
S. aureus ATCC 292131.253.13-
S. pneumoniae CCARM 00311.25--

References

  1. Gao L, Li H, Li B, Shao H, Yu X, Miao Z, et al. 2022. Traditional uses, phytochemistry, transformation of ingredients and pharmacology of the dried seeds of Raphanus sativus L. (Raphani Semen), A comprehensive review. J. Ethnopharmacol. 294: 115387.
    Pubmed CrossRef
  2. Zheng W, Li X, Zhang T, Wang J. 2022. Biological mechanisms and clinical efficacy of sulforaphane for mental disorders. Gen. Psychiatr. 35: e100700.
    Pubmed KoreaMed CrossRef
  3. Kow CS, Ramachandram DS, Hasan SS. 2022. Use of sulforaphane in COVID-19: Clinical trials are needed. Mol. Immunol. 145: 78-79.
    Pubmed KoreaMed CrossRef
  4. Dana AH, Alejandro SP. 2022. Role of sulforaphane in endoplasmic reticulum homeostasis through regulation of the antioxidant response. Life Sci. 299: 120554.
    Pubmed CrossRef
  5. Wang L, Jiang H, Liang X, Zhou W, Qiu Y, Xue C, et al. 2021. Preparation of sulforaphene from radish seed extracts with recombinant food-grade Yarrowia lipolytica harboring high myrosinase activity. J. Agric. Food Chem. 69: 5363-5371.
    Pubmed CrossRef
  6. Lim S, Han S-W, Kim J. 2016. Sulforaphene identified from radish (Raphanus sativus L.) seeds possesses antimicrobial properties against multidrug-resistant bacteria and methicillin-resistant Staphylococcus aureus. J. Funct.Foods 24: 131-141.
    CrossRef
  7. Gao L, Du F, Wang J, Zhao Y, Liu J, Cai D, et al. 2021. Examination of the differences between sulforaphane and sulforaphene in colon cancer: A study based on next-generation sequencing. Oncol. Lett. 22: 690.
    Pubmed KoreaMed CrossRef
  8. Zhang G, Jin C, Zhu Y, Fu F, Wang G, Li S. 2020. Sulforaphene inhibits the progression of osteosarcoma via regulating FSTL1/NF-κB pathway. Life Sci. 263: 118485.
    Pubmed CrossRef
  9. Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX. 2020. Sulforaphene ameliorates neuroinflammation and hyperphosphorylated tau protein via regulating the PI3K/Akt/GSK-3β pathway in experimental models of Alzheimer's disease. Oxid. Med. Cell Longev. 2020: 4754195.
    Pubmed KoreaMed CrossRef
  10. Yang H, Kang MJ, Hur G, Lee TK, Park IS, Seo SG, et al. 2020. Sulforaphene suppresses adipocyte differentiation via induction of post-translational degradation of CCAAT/enhancer binding protein Beta (C/EBPβ). Nutrients 12: 758.
    Pubmed KoreaMed CrossRef
  11. Valente Duarte De Sousa IC. 2019. New and emerging drugs for the treatment of acne vulgaris in adolescents. Expert Opin. Pharmacother. 20: 1009-1024.
    Pubmed CrossRef
  12. Williams HC, Dellavalle RP, Garner S. 2012. Acne vulgaris. Lancet 379: 361-372.
    Pubmed CrossRef
  13. Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. 2022. Acne treatment review and future perspectives. Dermatol. Ther. 35: e15719.
    CrossRef
  14. Andersen RK, Bouazzi D, Erikstrup C, Nielsen KR, Burgdorf KS, Bruun MT, et al. 2022. The social and psychological impact of acne treatment: A cross-sectional study of blood donors. J. Cutan. Med. Surg. 26: 485-493.
    Pubmed CrossRef
  15. Marron SE, Chernyshov PV, Tomas-Aragones L. 2019. Quality-of-life research in acne vulgaris: current status and future directions. Am. J. Clin. Dermatol. 20: 527-538.
    Pubmed CrossRef
  16. Tanghetti EA. 2013. The role of inflammation in the pathology of acne. J. Clin. Aesthet. Dermatol. 6: 27-35.
  17. Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, et al. 2014. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J. Eur. Acad. Dermatol. Venereol. 28: 271-278.
    Pubmed CrossRef
  18. Temiz SA, Daye M. 2022. Dapsone for the treatment of acne vulgaris: do the risks outweigh the benefits? Cutan. Ocul. Toxicol. 41: 60-66.
    Pubmed CrossRef
  19. Suh HD. 2010. Pharmacologic treatment acne. J. Korean Med. Assoc. 53: 623-629.
    CrossRef
  20. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. 2005. What is the pathogenesis of acne? Exp. Dermatol. 14: 143-152.
    Pubmed CrossRef
  21. Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. 2016. Guidelines of care for the management of acne vulgaris. J. Am. Acad. Dermatol. 74: 945-973.
    Pubmed CrossRef
  22. Boen M, Jacob C. 2019. A Review and update of treatment options using the acne scar classification system. Dermatol. Surg. 45: 411-422.
    Pubmed CrossRef
  23. Oh JH, Kim SH, Kwon OK, Kim JH, Oh SR, Han SB, et al. 2022. Purpurin suppresses atopic dermatitis via TNF-α/IFN-γ-induced inflammation in HaCaT cells. Int. J. Immunopathol. Pharmacol. 36: 3946320221111135.
    Pubmed KoreaMed CrossRef
  24. Jayasinghe AMK, Kirindage K, Fernando IPS, Han EJ, Oh GW, Jung WK, et al. 2022. Fucoidan Isolated from Sargassum confusum suppresses inflammatory responses and oxidative stress in TNF-α/IFN-γ-stimulated HaCaT keratinocytes by activating Nrf2/HO-1 signaling pathway. Mar. Drugs 20: 117.
    Pubmed KoreaMed CrossRef
  25. Heo Y, Yeo KU, Cha WS, Yeon DE, Choi SH, Lee JY, et al. 2013. Development of skin sensitization alternative test through co-culture of THP-1 dendritic cell line and HaCaT keratinocyte cell line. J. Alternat. Anim. Exp. 7: 29-34.
  26. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, et al. 2002. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169: 1535-1541.
    Pubmed KoreaMed CrossRef
  27. Chen Q, Koga T, Uchi H, Hara H, Terao H, Moroi Y, et al. 2002. Propionibacterium acnes-induced IL-8 production may be mediated by NF-κB activation in human monocytes. J. Dermatol. Sci. 29: 97-103.
    Pubmed CrossRef
  28. Zhang B, Choi YM, Lee J, An IS, Li L, He C, et al. 2019. Toll-like receptor 2 plays a critical role in pathogenesis of acne vulgaris. Biomed. Dermatol. 3: 4.
    CrossRef
  29. Hernandez-Quintero M, Kuri-Harcuch W, Gonzalez Robles A, Castro-Munozledo F. 2006. Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture. Cell Tissue Res. 325: 77-90.
    Pubmed CrossRef
  30. Dixit N, Simon SI. 2012. Chemokines, selectins and intracellular calcium flux: temporal and spatial cues for leukocyte arrest. Front. Immunol. 3: 188.
    Pubmed KoreaMed CrossRef
  31. Fang F, Xie Z, Quan J, Wei X, Wang L, Yang L. 2020. Baicalin suppresses Propionibacterium acnes-induced skin inflammation by downregulating the NF-κB/MAPK signaling pathway and inhibiting activation of NLRP3 inflammasome. Braz. J. Med. Biol. Res. 53: e9949.
    Pubmed KoreaMed CrossRef
  32. Kim J. 2005. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211: 193-198.
    Pubmed CrossRef
  33. Kistowska M, Gehrke S, Jankovic D, Kerl K, Fettelschoss A, Feldmeyer L, et al. 2014. IL-1beta drives inflammatory responses to propionibacterium acnes in vitro and in vivo. J. Invest. Dermatol. 134: 677-685.
    Pubmed CrossRef